NASDAQ: SONMDna X Inc Stock Ownership - Who owns Dna X?
Insider buying vs selling
Have Dna X Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Laurence W. Lytton | 10% Owner | 2025-06-30 | 400,514 | $1.39 | $556.71kSell |
| Laurence W. Lytton | 10% Owner | 2025-06-26 | 466,402 | $1.50 | $699.60kSell |
| Clayton Crolius | Chief Financial Officer | 2025-04-23 | 11,634 | $1.45 | $16.87kSell |
| Michael C. Mulica | Director | 2025-04-23 | 27,818 | $1.45 | $40.34kSell |
| Jack Steenstra | Director | 2025-04-23 | 23,381 | $1.45 | $33.90kSell |
| Charles Becher | Chief Commercial Officer and General Manager of North America | 2025-04-23 | 31,326 | $1.45 | $45.42kSell |
| Jeffrey Wang | Director | 2025-04-23 | 4,478 | $1.45 | $6.49kSell |
| James S. Cassano | Director | 2025-04-23 | 23,381 | $1.45 | $33.90kSell |
SONM insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when SONM insiders and whales buy or sell their stock.
SONM Shareholders
What type of owners hold Dna X Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| B Riley Financial Inc | 1,897.53% | 19,519,805 | $56.61M | Insider |
| Ajp Holding Company LLC | 1,892.06% | 19,463,452 | $56.44M | Insider |
| Nokomis Capital LLC | 291.21% | 2,995,703 | $8.69M | Insider |
| Jeffrey Wang | 191.28% | 1,967,647 | $5.71M | Insider |
| Orbic North America LLC | 189.30% | 1,947,345 | $5.65M | Insider |
| Stanley Morgan | 88.13% | 906,629 | $2.63M | Insider |
| Laurence W. Lytton | 77.77% | 800,000 | $2.32M | Insider |
| Thomas Wiley Wilkinson | 70.72% | 727,500 | $2.11M | Insider |
| Robert Plaschke | 49.02% | 504,250 | $1.46M | Insider |
| Robert L. Tirva | 30.58% | 314,619 | $912.40k | Insider |
SONM vs Communication Equipment Stocks
Dna X Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.